A new study in Science Translational Medicine, in which researchers mapped the hidden preclinical evolution of rheumatoid arthritis at the molecular level, could lead to the next leap in patient outcomes. The study has revealed that immune cells are primed to become troublesome years before the first RA symptoms appear
